Hancock Jaffe Laboratories Inc Ano de IPO
Qual é o Ano de IPO de Hancock Jaffe Laboratories Inc?
O Ano de IPO de Hancock Jaffe Laboratories Inc é 1970
Qual é a definição de Ano de IPO?
A oferta pública inicia (OPI)l é um tipo de oferta pública em que as ações de uma empresa geralmente são vendidas a investidores institucionais que, por sua vez, vendem para o público em geral, em uma bolsa de valores, pela primeira vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Ano de IPO de empresas na Setor Health Care em NASDAQ em comparação com Hancock Jaffe Laboratories Inc
O que Hancock Jaffe Laboratories Inc faz?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Empresas com ano de ipo semelhantes a Hancock Jaffe Laboratories Inc
- Vanguard FTSE Developed Europe ex UK ETF tem Ano de IPO de 1969
- Hancock Jaffe Laboratories Inc tem Ano de IPO de 1970
- PepsiCo Inc tem Ano de IPO de 1972
- Applied Materials tem Ano de IPO de 1972
- L&T Finance tem Ano de IPO de 1972
- Coca-Cola Consolidated Inc tem Ano de IPO de 1972
- GT Biopharma tem Ano de IPO de 1972
- Jacobs Solutions Inc tem Ano de IPO de 1972